Skip to content

Clinical study of Xinsanpin combined with Taiji ball on early exercise rehabilitation after percutaneous coronary intervention

Clinical study of Xinsanpin combined with Taiji ball on early exercise rehabilitation after percutaneous coronary intervention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000422
Enrollment
Unknown
Registered
2024-09-11
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Experimental group:Xinsanpin combined with Tai chi ball bedside rehabilitation treatment was carried out
Control Group:Basic western medicine therapy

Sponsors

Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Men and women between the ages of 18 and 65; 2) Meet the diagnostic criteria of acute myocardial infarction; (3) Patients who underwent PCI and implanted stents successfully had stable vital signs; (4) Stop taking the traditional Chinese medicine that has been taken for treatment for more than 2 weeks; 5) Voluntarily cooperate with the application of Xinsan acupuncture and tai chi ball exercise rehabilitation treatment; Those who meet the above five criteria at the same time are included in the study.

Exclusion criteria

Exclusion criteria: Uncontrolled hypertension (resting systolic pressure >220mm Hg or resting diastolic pressure >110mm Hg); (2) Complicated with aortic dissection severe coarctation of the aorta and aortic aneurysm rheumatic heart disease severe valvular heart disease primary cardiomyopathy obstructive hypertrophic cardiomyopathy dilated cardiomyopathy Keshanopathy myocarditis pulmonary heart disease recent stroke or transient ischemic attack acute respiratory failure Patients with cardiopulmonary and brain diseases such as arterial embolism or pulmonary embolism or pulmonary infarction recently; 3) Severe arrhythmias or uncontrolled arrhythmias such as ventricular tachycardia ventricular fibrillation and degree III atrioventricular block; (4) Patients with severe hepatic and renal insufficiency severe hematopoietic system abnormalities water and electrolyte abnormalities etc.; 5) Pregnant or lactating women; 6) Patients with mental disorders physical hearing language and other disorders that make it difficult to cooperate; Patients with uncontrollable infectious or non-infectious inflammatory diseases; 8 Exercise risk stratified assessment for high-risk patients; 9) Patients who have participated in other clinical studies in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Seattle Angina Scale;

Secondary

MeasureTime frame
Mental state assessment;Cardiac function assessment;WHOQOL-BREF Quality of Life Scale;TCM syndrome integral;Surgical site limb and length of stay were evaluated;

Countries

China

Contacts

Public Contactdongliyan

Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine

1970797346@qq.com13828808465

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026